Counterforce Health Team

Renewing Therakos CELLEX Photopheresis Coverage with UnitedHealthcare in New York: Timeline, Documentation & Appeal Options

Answer Box: Fast Track to Renewal Therakos CELLEX photopheresis renewal with UnitedHealthcare requires prior authorization renewal before your current approval expires. Submit renewal requests 10-14 days before expiration via the UHC provider portal with updated clinical documentation showing treatment response. For CTCL or GVHD patients, include response assessments, lab monitoring

The Requirements Checklist to Get Lumizyme (alglucosidase alfa) Covered by Blue Cross Blue Shield in Georgia: Prior Authorization, Appeals, and Documentation Guide

Answer Box: Getting Lumizyme Covered by Blue Cross Blue Shield in Georgia Blue Cross Blue Shield of Georgia (Anthem) requires prior authorization for Lumizyme (alglucosidase alfa) with confirmed Pompe disease diagnosis via enzyme/genetic testing. Submit PA requests through the Availity provider portal with baseline function tests and specialist prescriber

How to Get Turalio (pexidartinib) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Turalio Covered by Blue Cross Blue Shield in New Jersey Turalio (pexidartinib) requires prior authorization from all Blue Cross Blue Shield plans in New Jersey. Here's your fastest path to approval: 1. Enroll in TURALIO REMS first - both prescriber and patient must complete enrollment

How Long Does It Take to Get Rinvoq (Upadacitinib) Approved by Humana in Michigan? Complete Timeline & Appeal Guide

Answer Box: Getting Rinvoq (Upadacitinib) Covered by Humana in Michigan Standard timeline: 7-14 days for Humana prior authorization decisions in Michigan. Rinvoq requires PA due to step therapy requirements (failed TNF inhibitors) and safety monitoring. Fastest path: Submit complete documentation via CoverMyMeds portal with specialist notes, lab results, and prior

Renewing Pemazyre (Pemigatinib) Approval with UnitedHealthcare in Ohio: Complete 2025 Renewal Guide

Answer Box: Renewing Pemazyre with UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization renewal for Pemazyre (pemigatinib) every 12 months, with approval based on documented clinical response and absence of disease progression. Submit renewal requests 2-4 weeks before your current authorization expires through the UHC provider portal or by calling 866-889-8054.

How to Get Bylvay (odevixibat) Covered by Aetna (CVS Health) in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Bylvay (odevixibat) Covered by Aetna (CVS Health) in New York Bylvay (odevixibat) requires prior authorization from Aetna (CVS Health) and is typically non-formulary, requiring a medical exception. The fastest path: Have a pediatric hepatologist or gastroenterologist submit a complete PA packet through Aetna's provider portal

How to Get Rapivab (Peramivir) Covered by Blue Cross Blue Shield in North Carolina: Appeals, Forms, and State Protections

Answer Box: Getting Rapivab Covered by Blue Cross Blue Shield in North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Rapivab (peramivir), listed under "Prior Review" in their 2024-2025 formularies. To get approval: (1) Submit a PA request via the BCBS NC provider portal

Getting Blenrep (Belantamab Mafodotin) Covered by UnitedHealthcare in Illinois: PA Requirements, Appeals, and Cost Support

Answer Box: Getting Blenrep Covered by UnitedHealthcare in Illinois Important Update: Blenrep (belantamab mafodotin) was voluntarily withdrawn from the U.S. market in 2022. GSK resubmitted for FDA approval with a PDUFA date of October 23, 2025. Currently, access is limited to clinical trials or expanded access programs only. For

Aetna (CVS Health) Coverage Criteria for Ultomiris (ravulizumab) in New York: What Counts as "Medically Necessary"?

Answer Box: Getting Ultomiris Covered by Aetna (CVS Health) in New York Ultomiris (ravulizumab) requires prior authorization from Aetna (CVS Health) for all FDA-approved indications (PNH, aHUS, anti-AChR+ generalized myasthenia gravis, and NMOSD). Coverage requires meeting diagnosis-specific criteria, meningococcal vaccination, and documentation of clinical necessity. Quick start: 1) Verify your

How to Get Opdivo (Nivolumab) Covered by Aetna (CVS Health) in Washington: Complete Prior Authorization Guide

Answer Box: Getting Opdivo Covered by Aetna (CVS Health) in Washington Opdivo (nivolumab) requires prior authorization from Aetna (CVS Health) for all oncology indications in Washington. The fastest path to approval: 1) Verify if your plan uses medical or specialty pharmacy benefit, 2) Complete the Opdivo Injectable Medication Precertification Request